{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:57:32Z","timestamp":1790855852047,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Dent. Med"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to compare microRNA-21-5p expressions at the extraction wound in the maxillary bones of rats with medication-related osteonecrosis of the jaw (MRONJ) and normal rats at different time points.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In total, 18 female, 8-week-old Sprague-Dawley rats were randomly assigned to the experimental group (<jats:italic>n<\/jats:italic>\u2009=\u20099) and the control group (<jats:italic>n<\/jats:italic>\u2009=\u20099). To establish MRONJ in the right maxillary first molar area in the experimental group, zoledronate (66\u2005\u00b5g\/kg) and dexamethasone (5\u2005mg\/kg) were administered intraperitoneally every other day for 2\u2005weeks before tooth extraction. Normal saline was administered in the control group. After tooth extraction, the drugs were continuously administered until the experimental endpoints, namely 1, 14, and 28\u2005days post-tooth extraction. At each endpoint, three rats from each group were euthanized. The maxilla bones at the wound area were harvested. A real-time polymerase chain reaction (RT-PCR) was performed to compare the expression levels of miRNA-21-5p at each time point between the MRONJ group and the control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From their gross appearance, the rats that received zoledronate and dexamethasone developed MRONJ as demonstrated by non-healing wounds and exposed bone at 14 and 28\u2005days post-extraction in contrast to the controls. The RT-PCR showed that the expression levels of miRNA-21-5p were relatively higher in the MRONJ rats compared to the control rats at day 14 and then the difference was lower at day 28 post-tooth extraction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings indicated that the microRNA-21-5p expression levels varied during the socket healing process in the MRONJ rats, reaching a peak at 2 weeks after tooth extraction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdmed.2024.1477274","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T06:24:01Z","timestamp":1734416641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model"],"prefix":"10.3389","volume":"5","author":[{"given":"Manta","family":"Morakotsriwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theerapat","family":"Chanamuangkon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjalee","family":"Vacharaksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirawish","family":"Limlawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrendo.2011.146","article-title":"Antiresorptive therapies for osteoporosis: a clinical overview","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B3","first-page":"1032","volume-title":"Mayo Clinic Proceedings","author":"Drake","year":"2008"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","article-title":"Bisphosphonates: effects on osteoblast","volume":"68","author":"Maruotti","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1124\/mi.10.3.5","article-title":"Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition","volume":"10","author":"Drake","year":"2010","journal-title":"Mol Interv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00000421-200212001-00002","article-title":"Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis","volume":"25","author":"Green","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bjoms.2020.03.010","article-title":"Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis","volume":"58","author":"Murphy","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11709","DOI":"10.3390\/ijerph191811709","article-title":"Oral-health-related quality of life in patients with medication-related osteonecrosis of the jaw: a prospective clinical study","volume":"19","author":"Winter","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of oral and maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jds.2022.03.014","article-title":"Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: a retrospective cohort study","volume":"17","author":"Seki","year":"2022","journal-title":"J Dent Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/life10070099","article-title":"Oral surgical management of bone and soft tissues in MRONJ treatment: a decisional tree","volume":"10","author":"Marcian\u00f2","year":"2020","journal-title":"Life"},{"key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antibiotics10020195","article-title":"Conservative management of medication-related osteonecrosis of the jaws (MRONJ): a retrospective cohort study","volume":"10","author":"Varoni","year":"2021","journal-title":"Antibiotics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fgene.2019.00364","article-title":"Small non-coding RNAs: new class of biomarkers and potential therapeutic targets in neurodegenerative disease","volume":"10","author":"Watson","year":"2019","journal-title":"Front Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr Genomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41405-023-00177-1","article-title":"3D-printed TCP-HA scaffolds delivering MicroRNA-302a-3p improve bone regeneration in a mouse calvarial model","volume":"9","author":"Limlawan","year":"2023","journal-title":"BDJ Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/odi.13239","article-title":"MicroRNA-21 promotes orthodontic tooth movement by modulating the RANKL\/OPG balance in T cells","volume":"26","author":"Wu","year":"2020","journal-title":"Oral Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-018-0417-0","article-title":"Regulation of bone metabolism by microRNAs","volume":"16","author":"Taipaleenm\u00e4ki","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.3390\/ijms21176081","article-title":"The role of microRNAs in bone metabolism and disease","volume":"21","author":"Gao","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/JPER.19-0567","article-title":"miRNA-21 deficiency impairs alveolar socket healing in mice","volume":"91","author":"Strauss","year":"2020","journal-title":"J Periodontol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13287-019-1168-2","article-title":"miRNA-21 promotes osteogenesis via the PTEN\/PI3K\/Akt\/HIF-1\u03b1 pathway and enhances bone regeneration in critical size defects","volume":"10","author":"Yang","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1177\/0022034516657043","article-title":"microRNA-21 contributes to orthodontic tooth movement","volume":"95","author":"Chen","year":"2016","journal-title":"J Dent Res"},{"key":"B23","first-page":"201","article-title":"MicroRNA profiles associated with bone healing of the extraction socket in medication-related osteonecrosis of the jaw in rat model: a pilot study","author":"Surajkulwatana","year":"2020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid\u2013related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J Craniomaxillofac Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.actbio.2016.06.022","article-title":"Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model","volume":"42","author":"Kaibuchi","year":"2016","journal-title":"Acta Biomater"},{"key":"B26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jbmr.3292","article-title":"Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw\u2013like lesions in mice","volume":"33","author":"Kuroshima","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1600-0714.2010.00927.x","article-title":"An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague\u2013Dawley rats","volume":"39","author":"L\u00f3pez-Jornet","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/jcm12010381","article-title":"Clinicopathologic profile, management and outcome of sinonasal ameloblastoma\u2014a systematic review","volume":"12","author":"Mehta","year":"2023","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"B31","volume-title":"Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw: Dental Clinical Guidance","author":"Scotland","year":"2017"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1021429","DOI":"10.3389\/fphys.2023.1021429","article-title":"MicroRNA in medication related osteonecrosis of the jaw: a review","volume":"14","author":"Mohd Yunus","year":"2023","journal-title":"Front Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00277-018-3296-7","article-title":"Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw","volume":"97","author":"Musolino","year":"2018","journal-title":"Ann Hematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.7150\/ijms.27593","article-title":"Circulating microRNA panel as a novel biomarker to diagnose bisphosphonate-related osteonecrosis of the jaw","volume":"15","author":"Yang","year":"2018","journal-title":"Int J Med Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1007\/s13277-015-4391-1","article-title":"miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome","volume":"37","author":"Petriella","year":"2016","journal-title":"Tumor Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0222013","DOI":"10.1371\/journal.pone.0222013","article-title":"MicroRNA regulation in colorectal cancer tissue and serum","volume":"14","author":"Gmerek","year":"2019","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2017.09.119","article-title":"MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1\/5\/8-Runx2 pathway","volume":"493","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/cells9020479","article-title":"The role of miR-21 in osteoblasts\u2013osteoclasts coupling in vitro","volume":"9","author":"Smieszek","year":"2020","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-020-2145-y","article-title":"MiR-21-5p regulates extracellular matrix degradation and angiogenesis in TMJOA by targeting Spry1","volume":"22","author":"Ma","year":"2020","journal-title":"Arthritis Res Ther"}],"container-title":["Frontiers in Dental Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdmed.2024.1477274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T06:24:04Z","timestamp":1734416644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdmed.2024.1477274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":39,"alternative-id":["10.3389\/fdmed.2024.1477274"],"URL":"https:\/\/doi.org\/10.3389\/fdmed.2024.1477274","relation":{},"ISSN":["2673-4915"],"issn-type":[{"value":"2673-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"article-number":"1477274"}}